The Federal Trade Commission (FTC) has initiated legal action against telehealth company Hims & Hers, alleging that the firm transmitted sensitive customer health information to major social media platforms, including Meta and Snap, without explicit user consent.

According to regulatory filings, the telehealth provider shared data tracking user activity, treatment inquiries, and personal health metrics to optimize targeted advertising campaigns. Regulators contend that sharing identifiable health details violates consumer trust and breaches privacy standards established under federal protection acts.

Privacy advocates have intensified scrutiny of digital health platforms that utilize third-party tracking pixels. The FTC's complaint seeks strict injunctions against unauthorized data sharing practices, along with potential financial penalties to enforce stricter compliance in the digital healthcare space.

Hims & Hers has denied any wrongdoing, maintaining that its data processing procedures comply with existing privacy framework requirements. However, this case highlights a growing regulatory push across the United States to safeguard personal medical data from commercial exploitation by ad networks.